Intermittent prednisone therapy in Duchenne muscular dystrophy: A randomized controlled trial

Archives of Neurology

Volumn 62, Issue 1, 2005, Pages 128-132

  Beenakker, Ernesto A C ^a   Fock, Johanna M ^a   Van Tol, Marja J ^b   Maurits, Natalia M ^a   Koopman, Hendrik M ^c   Brouwer, Oebele F ^a   Van Der Hoeven, Johannes H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Rehabilitation Center De Hoogstraat   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ARTICLE; CHILD; CLIMBING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CUSHINGOID SYNDROME; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INTERMITTENT THERAPY; DUCHENNE MUSCULAR DYSTROPHY; EUPHORIA; HUMAN; HYPERACTIVITY; INCREASED APPETITE; IRRITABILITY; MUSCLE FORCE; MUSCLE FUNCTION; NETHERLANDS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CENTER; RUNNING; SIDE EFFECT; UNIVERSITY HOSPITAL;

ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; NEUROLOGIC EXAMINATION; PREDNISONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 12144263634     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.1.128     Document Type: Article

References (11)

1. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord. 2002;12:926-929.
2. Griggs RC, Moxley RT III, Mendell JR, et al; Clinical Investigation of Duchenne Dystrophy Group. Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response. Arch Neurol. 1991;48:383-388.
3. Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med. 1989;320:1592-1597.
4. Sansome A, Royston P, Dubowitz V. Steroids in Duchenne muscular dystrophy: pilot study of a new low-dosage schedule. Neuromuscul Disord. 1993;3:567-569.
5. Fenichel GM, Mendell JR, Moxley RT III, et al. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol. 1991;48:575-579.
6. Muntoni F, Fisher I, Morgan JE, Abraham D. Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul Disord. 2002;12(suppl 1):S162-S165.
7. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumater JB, Pellergrino RJ. Clinical trial in Duchenne dystrophy, I: the design of the protocol. Muscle Nerve. 1981;4:186-197.
8. Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics. 1999;16:605-625.
9. Kinali M, Mercuri E, Main M, Muntoni F, Dubowitz V. An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscul Disord. 2002;12(suppl 1):S169-S174.
10. Koopman HM, Theunissen NC, Vogels AG, et al. The DUX-25: a short-form questionnaire for measuring health related quality of life of children with a chronic illness [abstract]. Qual Life Res. 1988;7:619.
11. Van Essen AJ, Verheij JBGM, Reefhuis J, et al. The Natural History of Duchenne Muscular Dystrophy: Analysis of Data From Dutch Survey and Review of Age Related Events [thesis]. Groningen, the Netherlands: Groningen State University; 1997.